Safety profiles of methylphenidate, amphetamine, and atomoxetine: analysis of spontaneous reports submitted to the food and drug administration adverse event reporting system

• Main Authors: Wei Wei (Author), Li Chen (Author), Hui Zhou (Author), Jinfeng Liu (Author), Yue Zhang (Author), Shiyu Feng (Author), Yingtao Bai (Author), Yanen Leng (Author), En Chang (Author), Liang Huang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Methylphenidate, atomoxetine, and Amphetamine are the three most commonly used medications approved by the United States Food and Drug Administration (FDA) for the treatment of attention deficit/hyperactivity disorder (ADHD). However, a comprehensive analysis of their safety profiles acr...